New therapeutic strategies proposed for some lung and kidney cancers
New findings from researchers at The University of Texas MD Anderson Cancer Center about how some cancer cells become “addicted” to glucose could open up fresh approaches to therapy strategies for cancers with high levels of an amino acid transporter called solute carrier family 7 member 11 (SLC7A11). This includes lung cancer and renal cell carcinoma, the most common type of kidney cancer.
The study, led by Boyi Gan, Ph.D., of...
Combination creates powerful central memory T cells for cellular therapy
Treating T cells harvested from a patient with a combination of an epigenetic drug and a cytokine while expanding the cells in the lab re-programs...
Study sheds light on fatty acid’s role in “chemobrain” and multiple sclerosis
Medical experts have always known myelin, the protective coating of nerve cells, to be metabolically inert. A study led by The University...
Pembrolizumab shows promise for some advanced, hard-to-treat rare cancers
A study conducted by researchers at The University of Texas MD Anderson Cancer Center demonstrated acceptable toxicity and anti-tumor activity in patients with four types of advanced, hard-to-treat rare cancers. Study findings were published in the March 18 online issue of the Journal for ImmunoTherapy of Cancer.
The open-label, Phase II study followed 127 patients who had advanced rare cancers: squamous cell carcinoma of the skin...
